EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biomedical Applications of Nanomedicine in Chronic Kidney Disease

Marcia Bastos Convento, Rodolfo Gabriel Pierre Marchi, Adelson Fernandes da Silva, Fernanda Teixeira Borges

Bioengineering · 11.11.2026 · 13 (11) · 1336

DOI: 10.3390/bioengineering13111336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioengineering, online erschienen am 11.11.2026. Verfasst von Marcia Bastos Convento und 3 weiteren Autor:innen. Die Arbeit nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nanomedicine has expanded biomedical applications in chronic kidney disease (CKD), including diagnostics, monitoring, targeted therapy, and extracorporeal management. However, heterogeneity in materials, experimental models, and translational development complicates assessment of clinical progress. This review characterized major CKD nanomedicine applications and their documented translational stages.

Methods

English-language original studies indexed in PubMed/MEDLINE between 1 July 2021 and 1 July 2026 were organized into 11 overlapping thematic categories and classified according to their highest documented translational stage.

Results

Of 288 records identified, 160 studies across 91 journals were included. The most frequent categories were nanodiagnostics and biosensors (53 studies), nanotherapy for renal fibrosis (51), kidney-targeted drug delivery (28), and redox nanomedicine, inflammation, and oxidative stress (27). Diagnostic platforms more frequently reached human-sample validation or early clinical evaluation, whereas therapeutic approaches remained predominantly preclinical. Extracorporeal nanotechnologies were largely experimental, with limited human-sample evaluation.

Conclusions

CKD nanomedicine exhibits substantial technological diversity but uneven translational development. Progress toward clinical implementation requires standardized physicochemical characterization, reproducibility, independent validation, long-term safety assessment, manufacturing scalability, and rigorous comparisons with established standards of care using clinically meaningful outcomes.

Zitieren

APA

Convento, M. B., Marchi, R. G. P., Silva, A. F. D., & Borges, F. T. (2026). Biomedical Applications of Nanomedicine in Chronic Kidney Disease. Bioengineering, 13(11), 1336. https://doi.org/10.3390/bioengineering13111336

Vancouver

Convento MB, Marchi RGP, Silva AFD, Borges FT. Biomedical Applications of Nanomedicine in Chronic Kidney Disease. Bioengineering. 2026;13(11):1336. doi:10.3390/bioengineering13111336

BibTeX
@article{Convento2026,
  author = {Convento, Marcia Bastos and Marchi, Rodolfo Gabriel Pierre and Silva, Adelson Fernandes da and Borges, Fernanda Teixeira},
  title = {Biomedical Applications of Nanomedicine in Chronic Kidney Disease},
  journal = {Bioengineering},
  year = {2026},
  volume = {13},
  number = {11},
  pages = {1336},
  doi = {10.3390/bioengineering13111336}
}
Kostenlos starten →